Show simple item record

dc.contributor.authorGower, Shelley
dc.contributor.authorBartu, Anne
dc.contributor.authorIlett, K.
dc.contributor.authorDoherty, D.
dc.contributor.authorMcLaurin, R.
dc.contributor.authorHamilton, D.
dc.date.accessioned2017-01-30T12:51:36Z
dc.date.available2017-01-30T12:51:36Z
dc.date.created2014-01-16T20:01:03Z
dc.date.issued2014
dc.identifier.citationGower, Shelley and Bartu, Anne and Ilett, Kenneth F. and Doherty, Dorota and McLaurin, Renate and Hamilton, Dale. 2014. The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age. Journal of Human Lactation. 30 (2): pp.217-223.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/26075
dc.identifier.doi10.1177/0890334413517748
dc.description.abstract

Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatal. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatal. Further research using larger samples to assess possible developmental effects over longer periods of time is required.

dc.publisherSage Science Press
dc.subjectsubstance abuse
dc.subjectdrug-exposed infants
dc.subjectinfant health
dc.subjectbreastfeeding
dc.titleThe wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age
dc.typeJournal Article
dcterms.source.startPage1
dcterms.source.endPage7
dcterms.source.issn1552-5732
dcterms.source.titleJournal of Human Lactation
curtin.department
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record